Psoriasis is a skin condition characterized by the rapid buildup of skin cells, leading to scaling on the skin's surface. ... Some individuals with psoriasis also develop psoriatic arthritis, which causes joint pain, stiffness, and swelling. Systemic ... "Psoriasis - Psoriatic Arthritis". National Library of Medicine. 2019-02-20. Retrieved 2023-06-25. "Psoriatic Arthritis". ... psoriasis, rheumatoid arthritis, and systemic lupus erythematosus. Diagnosing autoimmune diseases can be challenging due to ...

April 1990). "Sulfasalazine improves psoriasis. A double-blind analysis". Archives of Dermatology. 126 (4): 487-493. doi: ... Sulfasalazine has been studied in cirrhosis, psoriasis, idiopathic urticaria, and amyloidosis. "Sulfasalazine Use During ...

57-82 [63]. ISBN 978-84-475-3285-8. National Psoriasis Foundation (2001-12-03). "The battle to save coal tar in California". ... www.psoriasis.org. Archived from the original on 2002-10-29. Retrieved 2023-06-29. U.S. Food and Drug Administration (2015-04- ... though coal tar in low concentrations is used as a topical medicine for conditions such as psoriasis. Coal and petroleum tar ... 01). "Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis". www.accessdata.fda.gov. Archived from ...

Krell J (2006). "Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept". J Am Acad ... Alefacept is indicated for the management of patients with moderate to severe chronic plaque psoriasis in adult patients who ... Due to availability of better tolerated and more efficacious molecules for psoriasis, alefacept was withdrawn from use by its ... Alefacept is used to control inflammation in moderate to severe psoriasis with plaque formation, where it interferes with ...

"2020.3.13.psoriasis , Our Dermatology Online journal" (in Polish). Retrieved 2022-03-10. Yap, Jeremy Kean Yi; Pickard, Benjamin ...

"FDA approves new psoriasis drug Cosentyx". U.S. Food and Drug Administration. 2015-01-21. Retrieved 2015-03-12. "First in the ... IL-17 promotes psoriasis by contributing to the inflammatory response that damages and overturns the keratinocyte cells of the ... April 2011). "Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model". Journal of ... Recent work suggests the IL-23/IL-17 pathway plays a major role in the autoimmune disorder psoriasis. In this condition, immune ...

During the period Aminopterin was marketed, the agent was used off-label to safely treat over 4,000 patients with psoriasis in ... Rees RB, Bennett JH, Hamlin EM, Maibach HI (December 1964). "Aminopterin for Psoriasis. A decade's observation". Arch Dermatol ...

ISBN 0-07-138076-0. "Psoriasis Aid.com". "medscape.com: Overview of Parapsoriasis". v t e (Articles with short description, ...

... expert on psoriasis; Chairman of the Division of Dermatology; Director of the Dermatology Residency program for Baylor ...

LL-37 is thought to play a role in psoriasis pathogenesis (along with other anti-microbial peptides). In psoriasis, damaged ... LL-37 has also been found to be a common auto-antigen in psoriasis; T-cells specific to LL-37 were found in the blood and skin ... Rendon A, Schäkel K (March 2019). "Psoriasis Pathogenesis and Treatment". International Journal of Molecular Sciences. 20 (6): ... in two thirds of patients with moderate to severe psoriasis. LL-37 binds to the peptide Ab, which is associated with ...

... is a regimen for treatment of moderate to severe plaque psoriasis using a combination of crude coal tar and ... With the increased use of biologic medications in treatment of moderate-to-severe psoriasis there has been a shift away from ... Menter, Alan; Cram, David L. (July 1983). "The Goeckerman regimen in two psoriasis day care centers". Journal of the American ... A 2007 comparative study of psoriasis treatment found Goeckerman therapy to be more efficacious at 12-weeks than biologics. It ...

"Spotlight on itolizumab in the treatment of psoriasis - current perspectives from India". Psoriasis: Targets and Therapy. 9: 19 ...

Electric current relieve psoriasis. The Sunday Times -23 May 1993. P.13 An End to Psoriasis (1990). On Stream, official ... He used it for the first time in the treatment of resistant skin burns, exophthalmos, psoriasis and aplastic anaemia. Although ... Fakhri, O (1990). Use of low voltage electric current in the treatment of psoriasis. Archives of Dermatological Research 282(3 ... Patent: Method for the treatment of psoriasis with electric current, 1996 (United States Patent 5501705). Patent: ...

Qayoom, S; Ahmad, QM (2003). "Psoriasis and Helicobacter pylori". Indian Journal of Dermatology, Venereology and Leprology. 69 ...

"UVB Phototherapy". National Psoriasis Foundation, USA. Archived from the original (php) on 22 June 2007. Retrieved 23 September ... Exposure to UVA, while the skin is hyper-photosensitive, by taking psoralens is an effective treatment for psoriasis. Due to ... As such, sunlight therapy can be a candidate for treatment of conditions such as psoriasis and exfoliative cheilitis, ... Modern phototherapy has been used to successfully treat psoriasis, eczema, jaundice, vitiligo, atopic dermatitis, and localized ...

Rendon, Adriana; Schäkel, Knut (23 March 2019). "Psoriasis Pathogenesis and Treatment". International Journal of Molecular ... cirrhosis Psychogenic stresses Onychophagia Trauma injury Occupational trauma Zinc deficiency Protein deficiency Psoriasis ...

In 1982 he delivered the Kung Sun Oh lecture, on the topic of psoriasis. Christophers, Enno (June 2001). "Psoriasis − ... Christophers, Enno (1996). "The Immunopathology of Psoriasis". International Archives of Allergy and Immunology. 110 (3): 199- ... epidemiology and clinical spectrum: Psoriasis − epidemiology and clinical spectrum". Clinical and Experimental Dermatology. 26 ...

"Biologic Medications for Psoriasis". Consumer Reports. August 2014. Retrieved 17 July 2017. Singh, JA; Christensen, R; Wells, ... Before using biologics to treat psoriasis, treatment with topical moisturizers or steroids, or light therapy may provide relief ...

Mary also has psoriasis. Carmela believes Mary is a "self-hating Italian" on account of her distaste for certain Italian- ...

... plaque psoriasis, hidradenitis suppurativa, and uveitis. In the EU it is indicated for the treatment of: plaque psoriasis (a ... Adalimumab has been shown to treat moderate to severe chronic plaque psoriasis in adults who have the condition in many areas ... "Treating psoriasis to prevent heart attacks and strokes". ScienceDaily. Archived from the original on 20 September 2018. ... January 2008). "Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial". Journal of the ...

Voorhees, J. J. (1983). "Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other ... Kragballe, K; Voorhees, J. J. (1985). "Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation". Acta ... Excessive 12-HETE production is implicated in psoriasis. 5-Hydroxyeicosatetraenoic acid 15-Hydroxyeicosatetraenoic acid Hamberg ... psoriasis, various forms of Ichthyosis including Congenital ichthyosiform erythroderma, and corneal inflammatory diseases. ...

"Psoriasis - Symptoms and causes". Mayo Clinic. Retrieved 10 March 2021. Jain, Kanti (1987). Luk, Ting-Shan (ed.). "Advances in ... Excimer Laser is also used for difficult-to-treat skin diseases including psoriasis and vitiligo. The most widespread ...

"2013 Walk to Cure Psoriasis - National Psoriasis Foundation , Walk to Cure Psoriasis". walk.psoriasis.org. Retrieved 2018-11-28 ...

ISBN 0-7216-2921-0. v t e (Articles with short description, Short description matches Wikidata, Psoriasis, All stub articles, ... The lesions may resemble psoriasis.: 195 Keratoderma blennorrhagicum is commonly seen as an additional feature of reactive ...

Psoriasis can develop into psoriatic arthritis. With psoriatic arthritis, most individuals develop the skin problem first and ... In this case, the arthritis is considered to be secondary to the main disease; these include: Psoriasis Reactive arthritis ... "Questions and Answers About Psoriasis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 2017-04-12. ...

"Icos Psoriasis Treatment Falls Short". Puget Sound Business Journal. June 6, 2003. Retrieved January 10, 2009. Timmerman, Luke ... They are: ICM3, an antibody blocking ICAM-3, designed to treat psoriasis. IC14, an antibody blocking CD14, designed to treat ... IC747 and IC776, two LFA-1 antagonists, designed to treat psoriasis. Resiniferatoxin (RTX), a naturally occurring capsaicin ... psoriasis, hemorrhagic shock, sexual dysfunction, benign prostatic hyperplasia, rheumatoid arthritis, emphysema, chronic ...

For plaque psoriasis, a low concentration of 0.05% to 1% anthralin incorporated into petrolatum or zinc paste can be applied ... In 1876, a patient of Balmano Squire who had mistaken his psoriasis to be ringworm told him that he had used the powder to ... Anthralin was found to be an effective treatment for psoriasis by Galewsky in 1916. Busse, Kristine L; Alikhan, Ali; Feldman, ... Steele, Tace; Rogers, Cindy J.; Jacob, Sharon E. (October 2007). "Herbal remedies for psoriasis: what are our patients taking ...

... in the sera and lesional skin tissues of psoriasis patients, and in the sera of multiple sclerosis patients. A novel effect of ... "Cytokine network in psoriasis revisited". European Cytokine Network. 22 (4): 160-8. doi:10.1684/ecn.2011.0294. PMID 22236965. ...

Raptiva (efalizumab), for psoriasis, later withdrawn in 2009 due to the risk of PML. Recormon/NeoRecormon (epoetin beta), for ... Soriatane/Neotigason (acitretin), for psoriasis. Tamiflu (oseltamivir), for influenza A and B (both treatment and prevention). ...

Raychaudhuri SK, Maverakis E, Raychaudhuri SP (January 2014). "Diagnosis and classification of psoriasis". Autoimmunity Reviews ...